MetaNovas Secures Funding Rounds as Agentic AI Pioneers Skincare Material Exploration

As "AI for Science" gains momentum, molecular research in laboratories is shifting from digitization to intelligentization.
MetaNovas, a tech company at the forefront of commercializing AI-designed new molecular materials, recently announced the successful completion of two funding rounds: Series A+ and Series A++. The round attracted a strong group of investors—Fuhua Capital, Hillhouse Capital, and the Kangaroo Mom Group—all active in the consumer health sector.
Moving Beyond "Generation-Heavy, Implementation-Light": Getting AI Molecules Out of the Lab
For years, AI in molecular research has faced a core challenge: it can generate countless new molecules via algorithms, but efficiently translating them into real-world production remains difficult. MetaNovas' key breakthrough lies in its Agentic AI R&D System:
Full-Chain Integration: Shifting beyond a focus on isolated technical points, it has achieved a critical leap from "AI-designed molecules" to "AI-implemented molecules."
Compliance and Registration: The AI-designed new molecules have successfully completed the full journey from lab research to consumer market application, and have also passed global new material compliance registration.
Capitalizing on the Consumer Health Market: Leading Brands in China and the U.S. Are Already Onboard
Unlike many AI projects still in the theoretical stage, MetaNovas' technology is already deeply embedded in our daily lives.
Implementation Results: Its self-developed new molecules have entered the supply chains of top cosmetics and medical device brands in both China and the United States.
Industrial Empowerment: By leveraging Agentic AI, brand owners can significantly shorten the development cycle for new ingredients and precisely target niche opportunities in the consumer health market.
Investor Confidence: The "Super Agent" Driving New Material Innovation
This funding round will primarily be used to deepen technology R&D and expand its industrial footprint. As Shanghai Yuanxin Zhiyao Technology Co., Ltd. (a related entity of MetaNovas) continues to drive material innovation through AI, the industry is beginning to glimpse a new possibility: AI is no longer just a scientist's assistant, but a "super agent" capable of completing the entire cycle from discovery to implementation on its own.
Related article
Adobe Unveils AI Assistant for Photoshop
Adobe announced on Tuesday that its AI assistant for Photoshop is becoming available to users in beta on the web and in the mobile apps. The company is also adding new AI-powered image editing capabilities to Firefly, its tool for media generation an
Higgsfield secures $400 million funding, reaching $5.4 billion valuation with investments from Goldman Sachs and Intel
AI video platform Higgsfield has secured $400 million in funding from DST Global, Goldman Sachs, Liberty Global, and Intel, achieving a $5.4 billion valuation, per the Financial Times. The two-year-old startup is rapidly scaling enterprise subscripti
Science Corporation implants vision-restoring chip in first Stargardt disease patient
Science Corporation CEO Max Hodak revealed that the company has successfully implanted its vision-restoring PRIMA chip into its first patient suffering from Stargardt disease, a hereditary condition that progressively destroys central vision. Hodak,
Related Special Topic Recommendations
Comments (0)
0/500

As "AI for Science" gains momentum, molecular research in laboratories is shifting from digitization to intelligentization.
MetaNovas, a tech company at the forefront of commercializing AI-designed new molecular materials, recently announced the successful completion of two funding rounds: Series A+ and Series A++. The round attracted a strong group of investors—Fuhua Capital, Hillhouse Capital, and the Kangaroo Mom Group—all active in the consumer health sector.
Moving Beyond "Generation-Heavy, Implementation-Light": Getting AI Molecules Out of the Lab
For years, AI in molecular research has faced a core challenge: it can generate countless new molecules via algorithms, but efficiently translating them into real-world production remains difficult. MetaNovas' key breakthrough lies in its Agentic AI R&D System:
Full-Chain Integration: Shifting beyond a focus on isolated technical points, it has achieved a critical leap from "AI-designed molecules" to "AI-implemented molecules."
Compliance and Registration: The AI-designed new molecules have successfully completed the full journey from lab research to consumer market application, and have also passed global new material compliance registration.
Capitalizing on the Consumer Health Market: Leading Brands in China and the U.S. Are Already Onboard
Unlike many AI projects still in the theoretical stage, MetaNovas' technology is already deeply embedded in our daily lives.
Implementation Results: Its self-developed new molecules have entered the supply chains of top cosmetics and medical device brands in both China and the United States.
Industrial Empowerment: By leveraging Agentic AI, brand owners can significantly shorten the development cycle for new ingredients and precisely target niche opportunities in the consumer health market.
Investor Confidence: The "Super Agent" Driving New Material Innovation
This funding round will primarily be used to deepen technology R&D and expand its industrial footprint. As Shanghai Yuanxin Zhiyao Technology Co., Ltd. (a related entity of MetaNovas) continues to drive material innovation through AI, the industry is beginning to glimpse a new possibility: AI is no longer just a scientist's assistant, but a "super agent" capable of completing the entire cycle from discovery to implementation on its own.
Adobe Unveils AI Assistant for Photoshop
Adobe announced on Tuesday that its AI assistant for Photoshop is becoming available to users in beta on the web and in the mobile apps. The company is also adding new AI-powered image editing capabilities to Firefly, its tool for media generation an
Higgsfield secures $400 million funding, reaching $5.4 billion valuation with investments from Goldman Sachs and Intel
AI video platform Higgsfield has secured $400 million in funding from DST Global, Goldman Sachs, Liberty Global, and Intel, achieving a $5.4 billion valuation, per the Financial Times. The two-year-old startup is rapidly scaling enterprise subscripti
Science Corporation implants vision-restoring chip in first Stargardt disease patient
Science Corporation CEO Max Hodak revealed that the company has successfully implanted its vision-restoring PRIMA chip into its first patient suffering from Stargardt disease, a hereditary condition that progressively destroys central vision. Hodak,





Home






